Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Tuberculosis refers to the infectious bacterial disease characterized by the growth of nodules (tubercles) in the tissues, especially the lungs.
Tuberculosis Diagnostics and Treatment market report explains the definition, types, applications, major countries, and major players of the Tuberculosis Diagnostics and Treatment market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Abbott Laboratories
GlaxoSmithKline
Becton Dickinson
Lupin
Epistem Holdings Plc
Eiken Chemical
F Hoffmann-La Roche Ag
Cepheid Inc
Thermo Fisher Scientific
Alere, Inc
Akonni Biosystems, Inc
Otsuka Novel Products, QIAGEN
Hologic Corporation
Labatec Pharma
Sandoz
bioMérieux Sa
Hain Lifesciences
Sanofi
Bio - Synth Inc
By Type:
Skin Testing
Laboratory Testing
By End-User:
Hospitals
Clinics
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Tuberculosis Diagnostics and Treatment Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Tuberculosis Diagnostics and Treatment Outlook to 2028- Original Forecasts
-
2.2 Tuberculosis Diagnostics and Treatment Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Tuberculosis Diagnostics and Treatment Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Tuberculosis Diagnostics and Treatment Market- Recent Developments
-
6.1 Tuberculosis Diagnostics and Treatment Market News and Developments
-
6.2 Tuberculosis Diagnostics and Treatment Market Deals Landscape
7 Tuberculosis Diagnostics and Treatment Raw Materials and Cost Structure Analysis
-
7.1 Tuberculosis Diagnostics and Treatment Key Raw Materials
-
7.2 Tuberculosis Diagnostics and Treatment Price Trend of Key Raw Materials
-
7.3 Tuberculosis Diagnostics and Treatment Key Suppliers of Raw Materials
-
7.4 Tuberculosis Diagnostics and Treatment Market Concentration Rate of Raw Materials
-
7.5 Tuberculosis Diagnostics and Treatment Cost Structure Analysis
-
7.5.1 Tuberculosis Diagnostics and Treatment Raw Materials Analysis
-
7.5.2 Tuberculosis Diagnostics and Treatment Labor Cost Analysis
-
7.5.3 Tuberculosis Diagnostics and Treatment Manufacturing Expenses Analysis
8 Global Tuberculosis Diagnostics and Treatment Import and Export Analysis (Top 10 Countries)
-
8.1 Global Tuberculosis Diagnostics and Treatment Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Tuberculosis Diagnostics and Treatment Export by Region (Top 10 Countries) (2017-2028)
9 Global Tuberculosis Diagnostics and Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Tuberculosis Diagnostics and Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Skin Testing Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Laboratory Testing Consumption and Growth Rate (2017-2022)
-
9.2 Global Tuberculosis Diagnostics and Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Tuberculosis Diagnostics and Treatment Market Analysis and Outlook till 2022
-
10.1 Global Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.2.2 Canada Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.2.3 Mexico Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.3.2 UK Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.3.3 Spain Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.3.4 Belgium Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.3.5 France Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.3.6 Italy Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.3.7 Denmark Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.3.8 Finland Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.3.9 Norway Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.3.10 Sweden Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.3.11 Poland Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.3.12 Russia Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.3.13 Turkey Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.4.2 Japan Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.4.3 India Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.4.4 South Korea Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.4.5 Pakistan Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.4.6 Bangladesh Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.4.7 Indonesia Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.4.8 Thailand Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.4.9 Singapore Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.4.10 Malaysia Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.4.11 Philippines Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.4.12 Vietnam Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.5.2 Colombia Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.5.3 Chile Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.5.4 Argentina Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.5.5 Venezuela Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.5.6 Peru Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.5.7 Puerto Rico Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.5.8 Ecuador Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.6.2 Kuwait Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.6.3 Oman Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.6.4 Qatar Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.6.5 Saudi Arabia Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.6.6 United Arab Emirates Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.7.2 South Africa Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.7.3 Egypt Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.7.4 Algeria Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
-
10.8.2 New Zealand Tuberculosis Diagnostics and Treatment Consumption (2017-2022)
11 Global Tuberculosis Diagnostics and Treatment Competitive Analysis
-
11.1 Abbott Laboratories
-
11.1.1 Abbott Laboratories Company Details
-
11.1.2 Abbott Laboratories Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Abbott Laboratories Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
11.1.4 Abbott Laboratories Tuberculosis Diagnostics and Treatment Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 GlaxoSmithKline
-
11.2.1 GlaxoSmithKline Company Details
-
11.2.2 GlaxoSmithKline Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 GlaxoSmithKline Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
11.2.4 GlaxoSmithKline Tuberculosis Diagnostics and Treatment Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Becton Dickinson
-
11.3.1 Becton Dickinson Company Details
-
11.3.2 Becton Dickinson Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Becton Dickinson Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
11.3.4 Becton Dickinson Tuberculosis Diagnostics and Treatment Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Lupin
-
11.4.1 Lupin Company Details
-
11.4.2 Lupin Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Lupin Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
11.4.4 Lupin Tuberculosis Diagnostics and Treatment Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Epistem Holdings Plc
-
11.5.1 Epistem Holdings Plc Company Details
-
11.5.2 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
11.5.4 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Eiken Chemical
-
11.6.1 Eiken Chemical Company Details
-
11.6.2 Eiken Chemical Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Eiken Chemical Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
11.6.4 Eiken Chemical Tuberculosis Diagnostics and Treatment Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 F Hoffmann-La Roche Ag
-
11.7.1 F Hoffmann-La Roche Ag Company Details
-
11.7.2 F Hoffmann-La Roche Ag Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 F Hoffmann-La Roche Ag Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
11.7.4 F Hoffmann-La Roche Ag Tuberculosis Diagnostics and Treatment Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Cepheid Inc
-
11.8.1 Cepheid Inc Company Details
-
11.8.2 Cepheid Inc Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Cepheid Inc Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
11.8.4 Cepheid Inc Tuberculosis Diagnostics and Treatment Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Thermo Fisher Scientific
-
11.9.1 Thermo Fisher Scientific Company Details
-
11.9.2 Thermo Fisher Scientific Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Thermo Fisher Scientific Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
11.9.4 Thermo Fisher Scientific Tuberculosis Diagnostics and Treatment Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Alere, Inc
-
11.10.1 Alere, Inc Company Details
-
11.10.2 Alere, Inc Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Alere, Inc Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
11.10.4 Alere, Inc Tuberculosis Diagnostics and Treatment Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Akonni Biosystems, Inc
-
11.11.1 Akonni Biosystems, Inc Company Details
-
11.11.2 Akonni Biosystems, Inc Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Akonni Biosystems, Inc Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
11.11.4 Akonni Biosystems, Inc Tuberculosis Diagnostics and Treatment Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Otsuka Novel Products, QIAGEN
-
11.12.1 Otsuka Novel Products, QIAGEN Company Details
-
11.12.2 Otsuka Novel Products, QIAGEN Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Otsuka Novel Products, QIAGEN Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
11.12.4 Otsuka Novel Products, QIAGEN Tuberculosis Diagnostics and Treatment Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Hologic Corporation
-
11.13.1 Hologic Corporation Company Details
-
11.13.2 Hologic Corporation Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Hologic Corporation Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
11.13.4 Hologic Corporation Tuberculosis Diagnostics and Treatment Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Labatec Pharma
-
11.14.1 Labatec Pharma Company Details
-
11.14.2 Labatec Pharma Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Labatec Pharma Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
11.14.4 Labatec Pharma Tuberculosis Diagnostics and Treatment Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Sandoz
-
11.15.1 Sandoz Company Details
-
11.15.2 Sandoz Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Sandoz Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
11.15.4 Sandoz Tuberculosis Diagnostics and Treatment Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 bioMérieux Sa
-
11.16.1 bioMérieux Sa Company Details
-
11.16.2 bioMérieux Sa Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 bioMérieux Sa Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
11.16.4 bioMérieux Sa Tuberculosis Diagnostics and Treatment Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Hain Lifesciences
-
11.17.1 Hain Lifesciences Company Details
-
11.17.2 Hain Lifesciences Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Hain Lifesciences Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
11.17.4 Hain Lifesciences Tuberculosis Diagnostics and Treatment Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Sanofi
-
11.18.1 Sanofi Company Details
-
11.18.2 Sanofi Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Sanofi Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
11.18.4 Sanofi Tuberculosis Diagnostics and Treatment Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Bio - Synth Inc
-
11.19.1 Bio - Synth Inc Company Details
-
11.19.2 Bio - Synth Inc Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Bio - Synth Inc Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
11.19.4 Bio - Synth Inc Tuberculosis Diagnostics and Treatment Product Portfolio
-
11.19.5 Recent Research and Development Strategies
12 Global Tuberculosis Diagnostics and Treatment Market Outlook by Types and Applications to 2028
-
12.1 Global Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Skin Testing Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Laboratory Testing Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Tuberculosis Diagnostics and Treatment Market Analysis and Outlook to 2028
-
13.1 Global Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.2.2 Canada Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.2.3 Mexico Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.3.2 UK Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.3.3 Spain Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.3.4 Belgium Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.3.5 France Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.3.6 Italy Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.3.7 Denmark Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.3.8 Finland Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.3.9 Norway Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.3.10 Sweden Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.3.11 Poland Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.3.12 Russia Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.3.13 Turkey Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.4.2 Japan Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.4.3 India Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.4.4 South Korea Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.4.8 Thailand Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.4.9 Singapore Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.4.11 Philippines Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.5.2 Colombia Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.5.3 Chile Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.5.4 Argentina Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.5.6 Peru Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.6.3 Oman Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.6.4 Qatar Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.7.2 South Africa Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.7.3 Egypt Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.7.4 Algeria Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Tuberculosis Diagnostics and Treatment Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Tuberculosis Diagnostics and Treatment
-
Figure of Tuberculosis Diagnostics and Treatment Picture
-
Table Global Tuberculosis Diagnostics and Treatment Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Tuberculosis Diagnostics and Treatment Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Skin Testing Consumption and Growth Rate (2017-2022)
-
Figure Global Laboratory Testing Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Tuberculosis Diagnostics and Treatment Consumption by Country (2017-2022)
-
Table North America Tuberculosis Diagnostics and Treatment Consumption by Country (2017-2022)
-
Figure United States Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Canada Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Mexico Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Tuberculosis Diagnostics and Treatment Consumption by Country (2017-2022)
-
Figure Germany Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure UK Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Spain Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Belgium Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure France Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Italy Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Denmark Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Finland Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Norway Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Sweden Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Poland Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Russia Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Turkey Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Table APAC Tuberculosis Diagnostics and Treatment Consumption by Country (2017-2022)
-
Figure China Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Thailand Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Singapore Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Philippines Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Table South America Tuberculosis Diagnostics and Treatment Consumption by Country (2017-2022)
-
Figure Brazil Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Colombia Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Chile Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Argentina Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Peru Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Table GCC Tuberculosis Diagnostics and Treatment Consumption by Country (2017-2022)
-
Figure Bahrain Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Oman Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Qatar Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Table Africa Tuberculosis Diagnostics and Treatment Consumption by Country (2017-2022)
-
Figure Nigeria Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Africa Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Egypt Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Algeria Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Table Oceania Tuberculosis Diagnostics and Treatment Consumption by Country (2017-2022)
-
Figure Australia Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Tuberculosis Diagnostics and Treatment Consumption and Growth Rate (2017-2022)
-
Table Abbott Laboratories Company Details
-
Table Abbott Laboratories Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
Table Abbott Laboratories Tuberculosis Diagnostics and Treatment Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
Table GlaxoSmithKline Tuberculosis Diagnostics and Treatment Product Portfolio
-
Table Becton Dickinson Company Details
-
Table Becton Dickinson Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Becton Dickinson Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
Table Becton Dickinson Tuberculosis Diagnostics and Treatment Product Portfolio
-
Table Lupin Company Details
-
Table Lupin Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lupin Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
Table Lupin Tuberculosis Diagnostics and Treatment Product Portfolio
-
Table Epistem Holdings Plc Company Details
-
Table Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
Table Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Product Portfolio
-
Table Eiken Chemical Company Details
-
Table Eiken Chemical Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eiken Chemical Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
Table Eiken Chemical Tuberculosis Diagnostics and Treatment Product Portfolio
-
Table F Hoffmann-La Roche Ag Company Details
-
Table F Hoffmann-La Roche Ag Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ag Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
Table F Hoffmann-La Roche Ag Tuberculosis Diagnostics and Treatment Product Portfolio
-
Table Cepheid Inc Company Details
-
Table Cepheid Inc Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cepheid Inc Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
Table Cepheid Inc Tuberculosis Diagnostics and Treatment Product Portfolio
-
Table Thermo Fisher Scientific Company Details
-
Table Thermo Fisher Scientific Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
Table Thermo Fisher Scientific Tuberculosis Diagnostics and Treatment Product Portfolio
-
Table Alere, Inc Company Details
-
Table Alere, Inc Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alere, Inc Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
Table Alere, Inc Tuberculosis Diagnostics and Treatment Product Portfolio
-
Table Akonni Biosystems, Inc Company Details
-
Table Akonni Biosystems, Inc Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Akonni Biosystems, Inc Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
Table Akonni Biosystems, Inc Tuberculosis Diagnostics and Treatment Product Portfolio
-
Table Otsuka Novel Products, QIAGEN Company Details
-
Table Otsuka Novel Products, QIAGEN Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Otsuka Novel Products, QIAGEN Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
Table Otsuka Novel Products, QIAGEN Tuberculosis Diagnostics and Treatment Product Portfolio
-
Table Hologic Corporation Company Details
-
Table Hologic Corporation Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hologic Corporation Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
Table Hologic Corporation Tuberculosis Diagnostics and Treatment Product Portfolio
-
Table Labatec Pharma Company Details
-
Table Labatec Pharma Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Labatec Pharma Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
Table Labatec Pharma Tuberculosis Diagnostics and Treatment Product Portfolio
-
Table Sandoz Company Details
-
Table Sandoz Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sandoz Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
Table Sandoz Tuberculosis Diagnostics and Treatment Product Portfolio
-
Table bioMérieux Sa Company Details
-
Table bioMérieux Sa Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table bioMérieux Sa Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
Table bioMérieux Sa Tuberculosis Diagnostics and Treatment Product Portfolio
-
Table Hain Lifesciences Company Details
-
Table Hain Lifesciences Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hain Lifesciences Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
Table Hain Lifesciences Tuberculosis Diagnostics and Treatment Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
Table Sanofi Tuberculosis Diagnostics and Treatment Product Portfolio
-
Table Bio - Synth Inc Company Details
-
Table Bio - Synth Inc Tuberculosis Diagnostics and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio - Synth Inc Tuberculosis Diagnostics and Treatment Main Business and Markets Served
-
Table Bio - Synth Inc Tuberculosis Diagnostics and Treatment Product Portfolio
-
Figure Global Skin Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Laboratory Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tuberculosis Diagnostics and Treatment Consumption Forecast by Country (2022-2028)
-
Table North America Tuberculosis Diagnostics and Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Tuberculosis Diagnostics and Treatment Consumption Forecast by Country (2022-2028)
-
Figure Germany Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Tuberculosis Diagnostics and Treatment Consumption Forecast by Country (2022-2028)
-
Figure China Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Tuberculosis Diagnostics and Treatment Consumption Forecast by Country (2022-2028)
-
Figure Brazil Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Tuberculosis Diagnostics and Treatment Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Tuberculosis Diagnostics and Treatment Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Tuberculosis Diagnostics and Treatment Consumption Forecast by Country (2022-2028)
-
Figure Australia Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Tuberculosis Diagnostics and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
